These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37414535)

  • 1. Tipping the scales towards routine APOE genotyping.
    Dunne R; Coulthard E
    J Neurol Neurosurg Psychiatry; 2023 Sep; 94(9):669. PubMed ID: 37414535
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease: clinical implications of the apolipoprotein E genotype.
    Farlow MR
    Neurology; 1997 May; 48(5 Suppl 6):S30-4. PubMed ID: 9153158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Just caring: the moral and economic costs of APOE genotyping for Alzheimer's disease.
    Fleck LM
    Ann N Y Acad Sci; 1996 Dec; 802():128-38. PubMed ID: 8993492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E Genotyping in Alzheimer's Disease. Chicago, Illinois, October 21-22, 1995. Proceedings.
    Ann N Y Acad Sci; 1996 Dec; 802():1-224. PubMed ID: 9012314
    [No Abstract]   [Full Text] [Related]  

  • 6. APOE in Alzheimer's disease and neurodegeneration.
    Butterfield DA; Johnson LA
    Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of Western diet and APOE genotype on Alzheimer's disease risk.
    Sullivan PM
    Neurobiol Dis; 2020 May; 138():104790. PubMed ID: 32032732
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.
    van Gool WA
    Ann N Y Acad Sci; 1996 Dec; 802():79-91. PubMed ID: 8993487
    [No Abstract]   [Full Text] [Related]  

  • 9. There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease.
    Corder EH; Saunders AM; Pericak-Vance MA; Roses AD
    Arch Neurol; 1995 Jul; 52(7):650-1. PubMed ID: 7619017
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
    Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.
    Relkin NR; Kwon YJ; Tsai J; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():149-76. PubMed ID: 8993494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and brain injury: apolipoprotein E.
    Samatovicz RA
    J Head Trauma Rehabil; 2000 Jun; 15(3):869-74. PubMed ID: 10785619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype and Alzheimer's disease.
    Noguchi S; Murakami K; Yamada N
    Lancet; 1993 Sep; 342(8873):737. PubMed ID: 8103832
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.
    Mauricio M; O'Hara R; Yesavage JA; Friedman L; Kraemer HC; Van De Water M; Murphy GM
    Am J Geriatr Psychiatry; 2000; 8(3):196-200. PubMed ID: 10910416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE and dementia - resequencing and genotyping in 105,597 individuals.
    Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
    Alzheimers Dement; 2020 Dec; 16(12):1624-1637. PubMed ID: 32808727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.
    Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
    Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease.
    Norrman J; Brookes AJ; Yates C; St Clair D
    Br J Psychiatry; 1995 Oct; 167(4):533-6. PubMed ID: 8829725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.
    Gabryelewicz T; Religa D; Styczynska M; Peplonska B; Pfeffer A; Wasiak B; Luczywek E; Golebiowski M; Androsiuk W; Czyzewski K; Przekop I; Barcikowska M
    Dement Geriatr Cogn Disord; 2002; 14(4):208-12. PubMed ID: 12411763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.